David F. Stroncek
National Institutes of Health(US)National Institutes of Health Clinical Center(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Blood disorders and treatments
Most-Cited Works
- → CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy(2017)1,320 cited
- → T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma(2018)782 cited
- → T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma(2016)754 cited
- → NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis(2016)749 cited
- → Transfusion-related acute lung injury: Definition and review(2005)720 cited
- → International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials(2015)503 cited